Fingerprint
Dive into the research topics where Michael Arad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A critical appraisal of the ACC statements and ESC guidelines on myocarditis and pericarditis
Arad, M. & Keren, A., 2026, (Accepted/In press) In: Trends in Cardiovascular Medicine.Research output: Contribution to journal › Editorial
-
Clinical Features and Outcomes of Acute Myocarditis in Patients with Swab-Confirmed Respiratory Viral Pathogens
Mulla, W., Yahav, D., Wieder, A., Davydov, G., Segev, A., Arad, M., Matetzky, S., Beigel, R. & Younis, A., Mar 2026, In: Israel Medical Association Journal. 28, 3, p. 141-145 5 p.Research output: Contribution to journal › Article › peer-review
-
Mavacamten Monotherapy in Real-World Patients With Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM
COLLIGO-HCM investigators, 1 Feb 2026, In: Circulation. Genomic and precision medicine. 19, 1, p. e005502Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Characteristics and Outcomes of Patients with Nonrheumatic Streptococcal Pharyngitis-Associated Myocarditis
Mulla, W., Younis, A., Zahalka, S., Wieder, A., Yahav, D., Segev, A., Mazin, I., Kuperstein, R., Arad, M., Matetzky, S. & Beigel, R., May 2025, In: American Journal of Medicine. 138, 5, p. 835-842.e2Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy
REDWOOD-HCM, SEQUOIA-HCM, and FOREST-HCM Investigators, 2025, In: JACC: Heart Failure.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations